IMMUNOMEDICS INC Business Finance Contracts & Agreements

Forms of Restricted Stock Units Notice and Restricted Stock Units Agreement (for Officers/Employees) under the Immunomedics, Inc. Amended and Restated 2014 Long-Term Plan (Filed With SEC on August 5, 2020)

Time-Based Restricted Stock Unit Agreement, dated as of April 16, 2020, by and between the Company and Harout Semerjian (Filed With SEC on May 6, 2020)

Nonqualified Stock Option Grant, dated as of April 16, 2020, by and between the Company and Harout Semerjian (Filed With SEC on May 6, 2020)

Underwriting Agreement by and among Immunomedics, Inc., Cowen and Company, LLC, BofA Securities, Inc. and Jefferies LLC, as representatives of the underwriters named therein,... (Filed With SEC on May 1, 2020)

Underwriting Agreement by and among the Company, Goldman Sachs & Co. LLC and BofA Securities, Inc., as representatives of the underwriters named therein, dated December 4, 2019 (Filed With SEC on December 9, 2019)

Nonqualified Stock Option Grant, dated as of July 11, 2018, between the Company and Kurt Andrews (Filed With SEC on November 7, 2018)

Nonqualified Stock Option Grant, dated as of September 24, 2018, between the Company and Jared Freedberg (Filed With SEC on November 7, 2018)

Form of Exchange Agreement, dated October 2, 2018, between the Company and certain of the Company's noteholders (Filed With SEC on November 7, 2018)

Underwriting Agreement by and among the Company, Morgan Stanley & Co. LLC, and Cowen and Company, LLC and Jefferies LLC, as representatives of the underwriters named therein,... (Filed With SEC on June 15, 2018)

Nonqualified Stock Option Grant, dated as of April 9, 2018, between the Company and Robert Iannone (Filed With SEC on May 9, 2018)

Common Stock Purchase Agreement, dated as of January 7, 2018, between the Company and RPI Finance Trust (Filed With SEC on May 9, 2018)

Funding Agreement, dated as of January 7, 2018, between the Company and RPI Finance Trust (Filed With SEC on May 9, 2018)

Nonqualified Stock Option Grant, dated as of December 7, 2017, between the Company and Michael Pehl (Filed With SEC on February 8, 2018)

Form of Exchange Agreement (Filed With SEC on September 15, 2017)

STOCK PURCHASE AGREEMENT (Filed With SEC on May 10, 2017)

WARRANT AGREEMENT (Filed With SEC on February 16, 2017)

WARRANT AGREEMENT (Filed With SEC on October 12, 2016)

IMMUNOMEDICS, INC. 10,000,000 Shares of Common Stock and Warrants to Purchase 10,000,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 11, 2016)

IMMUNOMEDICS, INC. 9,000,000Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 2, 2014)

IMMUNOMEDICS, INC. RESTRICTED STOCK UNIT ISSUANCE AGREEMENT RECITALS (Filed With SEC on August 22, 2013)

6,086,956 Shares IMMUNOMEDICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 22, 2013)

IMMUNOMEDICS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on February 8, 2012)

COLLATERAL ASSIGNMENT (Filed With SEC on September 13, 2007)

ADDENDUM TO RESTRICTED STOCK UNIT ISSUANCE AGREEMENT (Filed With SEC on September 13, 2007)

IMMUNOMEDICS, INC. RESTRICTED STOCK UNIT ISSUANCE AGREEMENT (Filed With SEC on September 13, 2007)

IMMUNOMEDICS, INC. NOTICE OF GRANT OF STOCK OPTION (Filed With SEC on September 13, 2007)

ADDENDUM TO STOCK OPTION AGREEMENT (Filed With SEC on September 13, 2007)

IMMUNOMEDICS, INC. STOCK OPTION AGREEMENT (Filed With SEC on September 13, 2007)

4,848,485 SHARES OF COMMON STOCK of IMMUNOMEDICS, INC. PLACEMENT AGENT AGREEMENT (Filed With SEC on May 2, 2007)

SUBSCRIPTION AGREEMENT (Filed With SEC on May 2, 2007)